Skip all navigation and go to page content
NN/LM Home About Us | Contact Us | Feedback |Site Map | Help | Bookmark and Share

FDA Approves First Medication to Reduce HIV Risk

“The Food and Drug Administration (FDA) has approved the new use of Truvada—to be taken once daily and used in combination with safer sex practices—to reduce the risk of sexually acquired HIV-1 infection in adults who do not have HIV but are at high risk of becoming infected. (HIV-1 is the most common form of HIV.)

In two large clinical trials, daily use of Truvada was shown to significantly reduce the risk of HIV infection

  • by 42 percent in a study sponsored by the National Institutes of Health (NIH) of about 2,500 HIV-negative gay and bisexual men and transgender women, and
  • by 75 percent in a study sponsored by the University of Washington of about 4,800 heterosexual couples in which one partner was HIV positive and the other was not.” [FDA Consumer Report, 16 July 2012]

Read the complete Consumer Report: http://1.usa.gov/M65AbP

Bookmark and Share

Leave a Reply

You must be logged in to post a comment.